News > Moderna set to enter final stage of mRNA-1237 vaccine human clinical trials

Moderna set to enter final stage of mRNA-1237 vaccine human clinical trials

DNA India | 15/07/2020 08:55 PM | Click to read full article

After proving effective against the SARS-CoV-2 coronavirus in all previous trials, US pharmaceutical firm Moderna Inc. is now all set to begin the final stage of human trials for their experimental COVID-19 vaccine.

In the two phases of the human trials, the vaccine has reportedly provoked safe immune responses in all 45 healthy volunteers. In the third phase, the scientists will administer the vaccine to 30,000 volunteers, the biggest and the most crucial phase of human clinical trials.

-